EN
DE
Home
About us
Biofronteras Expertise
Management and supervisory board
Product Pipeline
Clinical trials
Products
Product Portfolio
Investors & Media
Key stock information
Financial reports
Financial announcements
Shareholder structure
Corporate calendar
Corporate governance
Annual general meeting
Presentations & contact
Career
Careers
Contact
Biofrontera
Investors & Media
Financial announcements
Latest News Releases
04/14/2025 22:55
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FINANCIAL YEAR 2024
04/14/2025 21:35
PTA-Adhoc: Biofrontera AG: DISCLOSURE OF INSIDE INFORMATION PURSUANT TO ARTICLE 17 MAR
11/29/2024 18:14
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2024
11/28/2024 18:13
PTA-News: Biofrontera AG: ADJUSTMENT OF THE FORECAST FOR THE FINANCIAL YEAR 2024
10/16/2024 11:05
PTA-News: Biofrontera AG: Biofrontera announces agreement with Galenica AB for the promotion and distribution of Ovixan® in the United Kingdom
09/30/2024 15:05
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST HALF OF 2024
08/30/2024 14:35
PTA-News: Biofrontera AG: Successful Annual General Meeting with broad approval and new Supervisory Board members
08/14/2024 10:00
PTA-News: Biofrontera AG: Biofrontera announces agreement with LEO Pharma Germany for the promotion of Advantan® and Skinoren®
07/21/2024 14:45
PTA-Adhoc: Biofrontera AG: Legal dispute on import in the USA and resulting revised outlook
07/01/2024 10:55
PTA-News: Biofrontera AG: Biofrontera hosted CME-Certified Training "Photodynamic Therapy (PDT) at the Cutting Edge" in Berlin
Financial announcements
Financial announcements
Material News
Current & Archive (Related Party Transactions incl.)
Corporate News
Current & Archive
Voting Rights
Notifications
Current & Archive
Directors' Dealings
Current & Archive
